Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HTRA1-AS1 (HTRA1 and ARMS2 antisense RNA 1) is a long noncoding RNA that overlaps the chromosome 10q26 locus associated with age-related macular degeneration (AMD)[2][4][6]. This locus contains the protein-coding genes HTRA1 (a serine protease involved in extracellular matrix remodeling and vascular regulation) and ARMS2 (possibly involved in mitochondrial function in retinal cells). Most genetic, functional, and therapeutic research focuses on HTRA1 and ARMS2 themselves, particularly their risk alleles and protein functions, not on their antisense RNA. HTRA1-AS1 is not recognized as a receptor, enzyme, therapeutic target, or biomarker in current clinical or research literature. Structured data extraction should focus on the canonical protein-coding genes at this locus rather than the antisense transcript[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HTRA1 and ARMS2 antisense RNA 1 (HTRA1-AS1).